According to Alnylam Pharmaceuticals 's latest financial reports the company's current earnings (TTM) are -$0.98 B. a decrease over its 2021 earnings that were of -$0.71 B.The earnings displayed on this page is the company's Pretax Income.
Year | Earnings | Change |
---|---|---|
2022 | -$0.98 B | 36.93% |
2021 | -$0.71 B | -11.32% |
2020 | -$0.8 B | -14.88% |
2019 | -$0.94 B | 15.31% |
2018 | -$0.82 B | 62.91% |
2017 | -$0.51 B | 17.78% |
2016 | -$0.43 B | 43.44% |
2015 | -$0.3 B | 60.69% |
2014 | -$0.19 B | 98.2% |
2013 | -$92.95 M | |
2011 | -$54.82 M | 27.48% |
2010 | -$43.01 M | -8.52% |
2009 | -$47.01 M | 90.64% |
2008 | -$24.66 M | |
2006 | -$39.51 M | -9.13% |
2005 | -$43.48 M | 34.74% |
2004 | -$32.27 M | 36.79% |
2003 | -$23.59 M |
Company | Earnings | Earnings differencediff. | Country |
---|---|---|---|
![]() Novartis NVS | $8.37 B | -962.08% | ๐จ๐ญ Switzerland |
![]() Sanofi SNY | $11.49 B | -1,283.64% | ๐ซ๐ท France |
![]() Regeneron Pharmaceuticals REGN | $4.85 B | -600.38% | ๐บ๐ธ USA |
![]() Sarepta Therapeutics
SRPT | -$0.69 B | -28.94% | ๐บ๐ธ USA |
![]() Regulus Therapeutics RGLS | -$27.96 M | -97.12% | ๐บ๐ธ USA |
![]() OPKO Health
OPK | -$0.4 B | -59.68% | ๐บ๐ธ USA |
![]() Teva Pharmaceutical Industries TEVA | -$2.14 B | 119.97% | ๐ฎ๐ฑ Israel |
![]() Arrowhead Pharmaceuticals
ARWR | -$0.16 B | -83.80% | ๐บ๐ธ USA |